Effect of capecitabine on breast cancer patients with different estrogen receptor status
This meta-analysis is to compare the efficacy of capecitabine versus non-capecitabine chemotherapy on breast cancer patients with different estrogen receptor (ER) status. We searched relevant literatures from EMBASE, PubMed and OVID library to analyze pathologic complete response rate (PCR), overal...
Main Authors: | Gang Xu, Xin Lv, Ke Lu, Ming Hai Shen, Qing Hua Zhang, Wan Neng Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
Bangladesh Pharmacological Society
2020-04-01
|
Series: | Bangladesh Journal of Pharmacology |
Subjects: | |
Online Access: | https://www.banglajol.info/index.php/BJP/article/view/43522 |
Similar Items
-
Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative, metastatic breast cancer
by: Xue-Lian Chen, et al.
Published: (2016-04-01) -
The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer
by: I V Kolyadina, et al.
Published: (2018-09-01) -
Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage
by: Xiuwen Guan, et al.
Published: (2020-07-01) -
Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)
by: Katharine Thomas, et al.
Published: (2020-01-01) -
The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis
by: Xingfa Huo, et al.
Published: (2021-01-01)